Royal Bank Of Canada reiterated their hold rating on shares of Genesis Healthcare, Inc. (NYSE:GEN) in a research note issued to investors on Wednesday morning. Royal Bank Of Canada currently has a $2.00 price target on the stock.

Other research analysts have also issued reports about the company. Cantor Fitzgerald began coverage on Genesis Healthcare in a research report on Wednesday, July 5th. They set an overweight rating for the company. ValuEngine raised Genesis Healthcare from a strong sell rating to a sell rating in a research report on Thursday, June 8th.

Shares of Genesis Healthcare (GEN) opened at 1.01 on Wednesday. Genesis Healthcare has a 1-year low of $0.91 and a 1-year high of $4.75. The stock has a 50 day moving average price of $1.17 and a 200 day moving average price of $1.92. The firm’s market capitalization is $95.67 million.

ILLEGAL ACTIVITY WARNING: This story was first published by Daily Political and is owned by of Daily Political. If you are reading this story on another site, it was illegally copied and reposted in violation of U.S. & international copyright law. The correct version of this story can be read at https://www.dailypolitical.com/2017/09/17/royal-bank-of-canada-reiterates-hold-rating-for-genesis-healthcare-inc-gen.html.

A number of large investors have recently made changes to their positions in the stock. Schwab Charles Investment Management Inc. raised its position in Genesis Healthcare by 0.6% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 105,432 shares of the company’s stock worth $184,000 after purchasing an additional 646 shares during the last quarter. Alliancebernstein L.P. raised its position in Genesis Healthcare by 2.6% during the 1st quarter. Alliancebernstein L.P. now owns 83,126 shares of the company’s stock worth $219,000 after purchasing an additional 2,100 shares during the last quarter. Goldman Sachs Group Inc. raised its position in Genesis Healthcare by 6.2% during the 2nd quarter. Goldman Sachs Group Inc. now owns 90,612 shares of the company’s stock worth $158,000 after purchasing an additional 5,250 shares during the last quarter. Bank of New York Mellon Corp raised its position in Genesis Healthcare by 2.4% during the 1st quarter. Bank of New York Mellon Corp now owns 229,770 shares of the company’s stock worth $607,000 after purchasing an additional 5,451 shares during the last quarter. Finally, Teton Advisors Inc. raised its position in Genesis Healthcare by 19.0% during the 1st quarter. Teton Advisors Inc. now owns 50,000 shares of the company’s stock worth $132,000 after purchasing an additional 8,000 shares during the last quarter. 14.90% of the stock is owned by institutional investors and hedge funds.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services.

Receive News & Ratings for Genesis Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.